3M to Acquire Acelity

3m3M (NYSE: MMM) is to acquire global medical technology company Acelity, Inc., and its KCI subsidiaries worldwide, for a total enterprise value of approximately $6.7 billion.

The seller was a consortium comprised of funds advised by Apax Partners (the Apax Funds), together with controlled affiliates of Canada Pension Plan Investment Board (CPPIB) and the Public Sector Pension Investment Board (PSP Investments).

The total enterprise value was of approximately $6.7 billion, including assumption of debt, subject to closing and other adjustments.

Acelity is a global medical technology company focused on advanced wound care and specialty surgical applications marketed under the KCI brand.
The business introduced V.A.C.® Therapy – Negative Pressure Wound Therapy. Today, the KCI product offering also includes advanced wound dressings and negative pressure surgical incision management systems.
Acelity had 2018 revenues of $1.5 billion.

3M Medical Solutions offers a range of integrated products that include medical tapes, advanced and acute wound care dressings and products, sterilization products, and patient warming products that get deployed in impactful solutions.

The transaction is expected to close in the second half of 2019, subject to customary closing conditions and regulatory approvals. 3M will finance the transaction with a combination of available cash and proceeds from the issuance of new debt.



Join the discussion